Drug intelligence / Profile preview

ART12.11

Development stage
Preclinical
Lead developer
Artelo Biosciences
Modality
Small Molecules
Administration
Oral
01

Overview

**ART12.11** is Artelo Biosciences' proprietary oral crystalline cocrystal composition of cannabidiol and tetramethylpyrazine. The candidate is designed to improve cannabidiol solubility, stability, and systemic exposure relative to conventional cannabidiol formulations. In rodent chronic-stress models, oral ART12.11 produced antidepressant-like and anxiolytic-like effects that exceeded cannabidiol alone, tetramethylpyrazine alone, and a noncrystalline cannabidiol plus tetramethylpyrazine mixture. It is being developed for depressive and anxiety disorders, with human studies planned but not confirmed as initiated in public sources.

Other names
CBD:TMP cocrystalcannabidiol:tetramethylpyrazine cocrystal
02

Targets

CNR1 (Cannabinoid receptor 1)CaV (Voltage-gated calcium channel protein complex)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))

Beyond the preview

Go deeper on ART12.11.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ART12.11.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call